FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults
Pharmacy Times
JUNE 10, 2025
1 "[Meloxicam injection] demonstrates our commitment to improving patient care by providing an alternate dosage form for pain management," Ron Scarboro, chief executive officer at Azurity Pharmaceuticals, said in a press release. 2 REFERENCES 1. Meloxicam: Selective COX-2 inhibition in clinical practice. December 21, 2004.
73 
Let's personalize your content